Cerus ( CERS) was one of the best performers of Friday's session. After the previous close, the biotech company said it swung to a fourth-quarter profit that easily beat Wall Street's estimates. Cerus was recently up 33 cents, or 5.8%, to $6.07. Telik ( TELK) was also higher after the company late Thursday posted a narrower-than-expected fourth-quarter loss. The stock was rising 38 cents, or 7%, to $5.85. On the other hand, Gene Logic ( GLGC) slid 4.2% to $1.82 after the company said it may spin off its genomics division, which was once the company's core business. PDL BioPharma ( PDLI) was also moving lower more than a day after the company missed fourth-quarter earnings targets. The stock was losing 26 cents, or 1.3%, to $19.45. Among health care winners of the session, NeoPharm ( NEOL) surged 29.8% to $2.31. Celgene ( CELG) was adding 2.8% at $56.41. GlaxoSmithKline ( GSK) was higher by 1.1% to $57. Among decliners, Forest Laboratories ( FRX) was off 1.2% at $54.34. Humana ( HUM) was losing 1.1% to $61.61. UnitedHealth Group ( UNH) was down 1% to $53.19.